<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21873607</PMID><DateCompleted><Year>2012</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>22</Issue><PubDate><Year>2011</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Impaired motoneuronal retrograde transport in two models of SBMA implicates two sites of androgen action.</ArticleTitle><Pagination><StartPage>4475</StartPage><EndPage>4490</EndPage><MedlinePgn>4475-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddr380</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA) impairs motor function in men and is linked to a CAG repeat mutation in the androgen receptor (AR) gene. Defects in motoneuronal retrograde axonal transport may critically mediate motor dysfunction in SBMA, but the site(s) where AR disrupts transport is unknown. We find deficits in retrograde labeling of spinal motoneurons in both a knock-in (KI) and a myogenic transgenic (TG) mouse model of SBMA. Likewise, live imaging of endosomal trafficking in sciatic nerve axons reveals disease-induced deficits in the flux and run length of retrogradely transported endosomes in both KI and TG males, demonstrating that disease triggered in muscle can impair retrograde transport of cargo in motoneuron axons, possibly via defective retrograde signaling. Supporting the idea of impaired retrograde signaling, we find that vascular endothelial growth factor treatment of diseased muscles reverses the transport/trafficking deficit. Transport velocity is also affected in KI males, suggesting a neurogenic component. These results demonstrate that androgens could act via both cell autonomous and non-cell autonomous mechanisms to disrupt axonal transport in motoneurons affected by SBMA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kemp</LastName><ForeName>Michael Q</ForeName><Initials>MQ</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Michigan State University, 108 Giltner Hall, East Lansing, MI 48824, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poort</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Baqri</LastName><ForeName>Rehan M</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Breedlove</LastName><ForeName>S Marc</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Kyle E</ForeName><Initials>KE</Initials></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Cynthia L</ForeName><Initials>CL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32-MH070343</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS055746</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1F32AR055848-01</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS045195</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000728" MajorTopicYN="N">Androgens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008817" MajorTopicYN="N">Mice, Mutant Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21873607</ArticleId><ArticleId IdType="pmc">PMC3196895</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddr380</ArticleId><ArticleId IdType="pii">ddr380</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Perlson E., Maday S., Fu M.M., Moughamian A.J., Holzbaur E.L. Retrograde axonal transport: pathways to cell death? Trends Neurosci. 2010;33:335&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902719</ArticleId><ArticleId IdType="pubmed">20434225</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G.A., Burns M., Binder L.I., Kanaan N.M., LaPointe N., Bosco D.A., Brown R.H., Jr, Brown H., Tiwari A., Hayward L., et al. Axonal transport defects in neurodegenerative diseases. J. Neurosci. 2009;29:12776&#x2013;12786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2801051</ArticleId><ArticleId IdType="pubmed">19828789</ArticleId></ArticleIdList></Reference><Reference><Citation>King S.J., Schroer T.A. Dynactin increases the processivity of the cytoplasmic dynein motor. Nat. Cell Biol. 2000;2:20&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">10620802</ArticleId></ArticleIdList></Reference><Reference><Citation>Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., et al. Mutant dynactin in motor neuron disease. Nat. Genet. 2003;33:455&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">12627231</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A.D., Kurt A., Prudlo J., Peraus G., Hanemann C.O., Stumm G., et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004;63:724&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">15326253</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Minamiyama M., Waza M., Tokui K., Banno H., Suzuki K., Onoda Y., Tanaka F., Doyu M., et al. Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. J. Neurosci. 2006;26:12106&#x2013;12117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6675422</ArticleId><ArticleId IdType="pubmed">17122035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy W.R., Alter M., Sung J.H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H., Katsuno M., Suzuki K., Takeuchi Y., Kawashima M., Suga N., Takamori M., Ito M., Nakamura T., Matsuo K., et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann. Neurol. 2009;65:140&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">19259967</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeyama K., Ito S., Yamamoto A., Tanimoto H., Furutani T., Kanuka H., Miura M., Tabata T., Kato S. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron. 2002;35:855&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372281</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie H.L., Merry D.E. Autophagy and access: understanding the role of androgen receptor subcellular localization in SBMA. Autophagy. 2009;5:1194&#x2013;1197.</Citation><ArticleIdList><ArticleId IdType="pubmed">19770590</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen E.S., O'Brien C.J., Wang H., Jenkins S.C., Holder L., Lieberman A.P., Merry D.E. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 2004;24:4778&#x2013;4786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., Sang C., Kobayashi Y., Doyu M., Sobue G. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35:843&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Dadgar N., Albertelli M., Gruis K., Jordan C., Robins D.M., Lieberman A.P. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Invest. 2006;116:2663&#x2013;2672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G., Pigino G., Szebenyi G., You Y., Pollema S., Brady S.T. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 2006;9:907&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pubmed">16751763</ArticleId></ArticleIdList></Reference><Reference><Citation>Szebenyi G., Morfini G.A., Babcock A., Gould M., Selkoe K., Stenoien D.L., Young M., Faber P.W., MacDonald M.E., McPhaul M.J., et al. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron. 2003;40:41&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">14527432</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccioni F., Pinton P., Simeoni S., Pozzi P., Fascio U., Vismara G., Martini L., Rizzuto R., Poletti A. Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. FASEB J. 2002;16:1418&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pubmed">12205033</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B., Nirmalananthan N., Bilsland L.G., La Spada A.R., Hanna M.G., Schiavo G., Gallo J.M., Greensmith L. Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2011;20:1776&#x2013;1786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071673</ArticleId><ArticleId IdType="pubmed">21317158</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks D.A., Johansen J.A., Mo K., Rao P., Eagleson B., Yu Z., Lieberman A.P., Breedlove S.M., Jordan C.L. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl Acad. Sci. USA. 2007;104:18259&#x2013;18264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky N.B., Pennuto M., Smith R.B., Palazzolo I., Moore J., Nie Z., Neale G., Taylor J.P. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron. 2010;67:936&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagot Y., Rosse T., Vejsada R., Perrelet D., Kato A.C. Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease. J. Neurosci. 1998;18:1132&#x2013;1141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792750</ArticleId><ArticleId IdType="pubmed">9437033</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen J.A., Troxell S.M., Yu Z., Mo K., Monks D.A., Lieberman A.P., Breedlove S.M., Jordan C.L. Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy. Neurodegener. Dis. 2011;8:25&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3030474</ArticleId><ArticleId IdType="pubmed">20689246</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen J.A., Yu Z., Mo K., Monks D.A., Lieberman A.P., Breedlove S.M., Jordan C.L. Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy. Neurobiol. Dis. 2009;34:113&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209964</ArticleId><ArticleId IdType="pubmed">19211034</ArticleId></ArticleIdList></Reference><Reference><Citation>Misgeld T., Kerschensteiner M., Bareyre F.M., Burgess R.W., Lichtman J.W. Imaging axonal transport of mitochondria in vivo. Nat. Methods. 2007;4:559&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">17558414</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcroix J.D., Valletta J.S., Wu C., Hunt S.J., Kowal A.S., Mobley W.C. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron. 2003;39:69&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">12848933</ArticleId></ArticleIdList></Reference><Reference><Citation>Viancour T.A., Kreiter N.A. Vesicular fast axonal transport rates in young and old rat axons. Brain Res. 1993;628:209&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">8313149</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlson E., Jeong G.B., Ross J.L., Dixit R., Wallace K.E., Kalb R.G., Holzbaur E.L. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J. Neurosci. 2009;29:9903&#x2013;9917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3095444</ArticleId><ArticleId IdType="pubmed">19657041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopher B.L., Thomas P.S., Jr, LaFevre-Bernt M.A., Holm I.E., Wilke S.A., Ware C.B., Jin L.W., Libby R.T., Ellerby L.M., La Spada A.R. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron. 2004;41:687&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15003169</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady S., Morfini G. A perspective on neuronal cell death signaling and neurodegeneration. Mol. Neurobiol. 2010;42:25&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3693570</ArticleId><ArticleId IdType="pubmed">20480262</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K., Katsuno M., Banno H., Takeuchi Y., Atsuta N., Ito M., Watanabe H., Yamashita F., Hori N., Nakamura T., et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain. 2008;131:229&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">18056738</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux S., Colasante C., Saint Cloment C., Barbier J., Curie T., Girard E., Molgo J., Brulet P. Internalization of a GFP-tetanus toxin C-terminal fragment fusion protein at mature mouse neuromuscular junctions. Mol. Cell Neurosci. 2005;30:79&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">16023367</ArticleId></ArticleIdList></Reference><Reference><Citation>Devon R.S., Orban P.C., Gerrow K., Barbieri M.A., Schwab C., Cao L.P., Helm J.R., Bissada N., Cruz-Aguado R., Davidson T.L., et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc. Natl Acad. Sci. USA. 2006;103:9595&#x2013;9600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1480452</ArticleId><ArticleId IdType="pubmed">16769894</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquier A., Buhler E., Schafer M.K., Bohl D., Blanchard S., Beclin C., Haase G. Alsin/Rac1 signaling controls survival and growth of spinal motoneurons. Ann. Neurol. 2006;60:105&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">16802292</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen E.S., Wallace K.E., Pennise C.R., Holzbaur E.L. Lysosomal proliferation and distal degeneration in motor neurons expressing the G59S mutation in the p150Glued subunit of dynactin. Hum. Mol. Genet. 2008;17:1946&#x2013;1955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2584350</ArticleId><ArticleId IdType="pubmed">18364389</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C., Lin X., Chandran J., Shim H., Yang W.J., Cai H. The G59S mutation in p150(glued) causes dysfunction of dynactin in mice. J. Neurosci. 2007;27:13982&#x2013;13990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2367233</ArticleId><ArticleId IdType="pubmed">18094236</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M., Iyadurai S.J., Gassman A., Gindhart J.G., Jr, Hays T.S., Saxton W.M. Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport. Mol. Biol. Cell. 1999;10:3717&#x2013;3728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25669</ArticleId><ArticleId IdType="pubmed">10564267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S., Harmison G.G., Meyertholen K., Pennuto M., Burnett B.G., Fischbeck K.H. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2009;18:27&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2644643</ArticleId><ArticleId IdType="pubmed">18824496</ArticleId></ArticleIdList></Reference><Reference><Citation>Baqri R.M., Turner B.A., Rheuben M.B., Hammond B.D., Kaguni L.S., Miller K.E. Disruption of mitochondrial DNA replication in Drosophila increases mitochondrial fast axonal transport in vivo. PLoS ONE. 2009;4:e7874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773408</ArticleId><ArticleId IdType="pubmed">19924234</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie H.L., Cho M.S., Holder L., Tsvetkov A.S., Finkbeiner S., Merry D.E. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2009;18:1937&#x2013;1950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou C.Y., Poon V.Y., Maeder C.I., Watanabe S., Lehrman E.K., Fu A.K., Park M., Fu W.Y., Jorgensen E.M., Ip N.Y., et al. Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell. 2010;141:846&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168554</ArticleId><ArticleId IdType="pubmed">20510931</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronfman F.C., Tcherpakov M., Jovin T.M., Fainzilber M. Ligand-induced internalization of the p75 neurotrophin receptor: a slow route to the signaling endosome. J. Neurosci. 2003;23:3209&#x2013;3220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742322</ArticleId><ArticleId IdType="pubmed">12716928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronfman F.C., Escudero C.A., Weis J., Kruttgen A. Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev. Neurobiol. 2007;67:1183&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pubmed">17514710</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo K., Razak Z., Rao P., Yu Z., Adachi H., Katsuno M., Sobue G., Lieberman A.P., Westwood J.T., Monks D.A. Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy. PLoS ONE. 2010;5:e12922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2944863</ArticleId><ArticleId IdType="pubmed">20886071</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosker K.E., Courchesne S.L., Segal R.A. Action in the axon: generation and transport of signaling endosomes. Curr. Opin. Neurobiol. 2008;18:270&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693191</ArticleId><ArticleId IdType="pubmed">18778772</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I., Stack C., Kong L., Musaro A., Adachi H., Katsuno M., Sobue G., Taylor J.P., Sumner C.J., Fischbeck K.H., et al. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron. 2009;63:316&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735765</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., Musaro A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell Biol. 2005;168:193&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2171577</ArticleId><ArticleId IdType="pubmed">15657392</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Brakefield D., Pan Y., Hunter D., Myckatyn T.M., Parsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp. Neurol. 2007;203:457&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">17034790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciriza J., Moreno-Igoa M., Calvo A.C., Yague G., Palacio J., Miana-Mena F.J., Munoz M.J., Zaragoza P., Brulet P., Osta R. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model. Restor. Neurol. Neurosci. 2008;26:459&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">19096133</ArticleId></ArticleIdList></Reference><Reference><Citation>Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.P., Appelmans S., Oh H., Van Damme P., Rutten B., Man W.Y., De Mol M., et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 2005;8:85&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">15568021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondell M., Sundler F., Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 2000;12:4243&#x2013;4254.</Citation><ArticleIdList><ArticleId IdType="pubmed">11122336</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003;302:841.</Citation><ArticleIdList><ArticleId IdType="pubmed">14593171</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D., Haasdijk E.D., Grashorn J.A., Hawkins R., van Duijn W., Verspaget H.W., London J., Holstege J.C. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 2000;7:623&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">11114261</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., She W.C., Luchak J.M., Martinez P., Turiegano E., Benito J., Capovilla M., Skinner P.J., et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 2000;408:101&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">11081516</ArticleId></ArticleIdList></Reference><Reference><Citation>Duvick L., Barnes J., Ebner B., Agrawal S., Andresen M., Lim J., Giesler G.J., Zoghbi H.Y., Orr H.T. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Neuron. 2010;67:929&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2946945</ArticleId><ArticleId IdType="pubmed">20869591</ArticleId></ArticleIdList></Reference><Reference><Citation>Emamian E.S., Kaytor M.D., Duvick L.A., Zu T., Tousey S.K., Zoghbi H.Y., Clark H.B., Orr H.T. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron. 2003;38:375&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">12741986</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariotti C., Castellotti B., Pareyson D., Testa D., Eoli M., Antozzi C., Silani V., Marconi R., Tezzon F., Siciliano G., et al. Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul. Disord. 2000;10:391&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">10899444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Martin L.J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.J., Lu Y.Y., Muramatsu S., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Matsushita T., Hanazono Y., Kume A., et al. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci. 2002;22:6920&#x2013;6928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6757879</ArticleId><ArticleId IdType="pubmed">12177190</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohajeri M.H., Figlewicz D.A., Bohn M.C. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum. Gene Ther. 1999;10:1853&#x2013;1866.</Citation><ArticleIdList><ArticleId IdType="pubmed">10446925</ArticleId></ArticleIdList></Reference><Reference><Citation>Riddoch-Contreras J., Yang S.Y., Dick J.R., Goldspink G., Orrell R.W., Greensmith L. Mechano-growth factor, an IGF-I splice variant, rescues motoneurons and improves muscle function in SOD1(G93A) mice. Exp. Neurol. 2009;215:281&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">19038252</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., Carmeliet P., Mazarakis N.D. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004;429:413&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">15164063</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.J., Zup S.L., Verhovshek T., Sengelaub D.R., Forger N.G. Castration reduces motoneuron soma size but not dendritic length in the spinal nucleus of the bulbocavernosus of wild-type and BCL-2 overexpressing mice. J. Neurobiol. 2002;53:403&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">12382267</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuloaga D.G., Morris J.A., Monks D.A., Breedlove S.M., Jordan C.L. Androgen-sensitivity of somata and dendrites of spinal nucleus of the bulbocavernosus (SNB) motoneurons in male C57BL6J mice. Horm. Behav. 2007;51:207&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2584578</ArticleId><ArticleId IdType="pubmed">17126837</ArticleId></ArticleIdList></Reference><Reference><Citation>Konigsmark B.W. In: Contempory Research Methods in Neuroanatomy. Nauta W.J.H., Ebbeson S.O.E., editors. New York: Springer-Verlag; 1970. pp. 315&#x2013;340.</Citation></Reference><Reference><Citation>Miller K.E., DeProto J., Kaufmann N., Patel B.N., Duckworth A., Van Vactor D. Direct observation demonstrates that Liprin-alpha is required for trafficking of synaptic vesicles. Curr. Biol. 2005;15:684&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pubmed">15823543</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 2000;28:41&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">11086982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan C.L., Williams T.J. Testosterone regulates terminal Schwann cell number and junctional size during developmental synapse elimination. Dev. Neurosci. 2001;23:441&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">11872945</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>